Inhibrx Biosciences, Inc. (INBX)
NASDAQ · Healthcare
Inhibrx Biosciences, Inc. Income Statement 2023–2025
| Dec 2025 | Dec 2024 | Dec 2023 | |
|---|---|---|---|
| Revenues | |||
| Revenue | 1.3M | 200,000 | 1.8M |
| Gross Profit | — | — | — |
| Profitability | |||
| Operating Income | -135.0M | -331.4M | -219.2M |
| EBITDA | — | — | — |
| Net Income | -140.1M | 1.69B | -241.4M |
| Per Share Data | |||
| EPS (diluted) | — | — | — |
| Shares Outstanding (dil.) | 15M | 15M | 12M |
Inhibrx Biosciences, Inc. Income Statement — FAQ
Inhibrx Biosciences, Inc. (INBX) income statement over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see INBX's income statement history?
The chart and table above show Inhibrx Biosciences, Inc.'s income statement by year and by quarter, including the growth rate.